Takara Bio Inc. (TYO:4974)
Japan · Delayed Price · Currency is JPY 1,142.00
0.00 (0.00%)
May 12, 2026, 3:30 PM JST
Takara Bio Cash Flow Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Net Income | -6,244 | 1,997 | 2,853 | 21,224 | 27,532 | 13,552 |
Depreciation & Amortization | 5,111 | 4,481 | 5,021 | 4,735 | 4,149 | 3,786 |
Loss (Gain) From Sale of Assets | 534 | 511 | 551 | 97 | 336 | 97 |
Asset Writedown & Restructuring Costs | 3,762 | - | - | - | - | - |
Other Operating Activities | 519 | -11 | -2,812 | -9,245 | -5,240 | -1,675 |
Change in Accounts Receivable | 131 | -2,250 | 1,501 | 5,718 | -4,812 | -3,559 |
Change in Inventory | 2,038 | 102 | -324 | 13,510 | -14,233 | -1,767 |
Change in Accounts Payable | 195 | 1,592 | -4,367 | 139 | -431 | 1,016 |
Change in Other Net Operating Assets | -1,820 | -578 | -712 | 719 | -316 | 2,493 |
Operating Cash Flow | 4,226 | 5,844 | 1,711 | 36,897 | 6,985 | 13,943 |
Operating Cash Flow Growth | -30.86% | 241.56% | -95.36% | 428.23% | -49.90% | 119.96% |
Capital Expenditures | -12,610 | -9,871 | -12,778 | -5,747 | -12,403 | -8,687 |
Sale of Property, Plant & Equipment | 31 | 5 | 9 | 396 | 47 | 14 |
Cash Acquisitions | -6,962 | -546 | - | - | - | - |
Investment in Securities | -37 | -94 | 713 | -1,215 | 1,471 | 3,153 |
Other Investing Activities | -364 | -406 | -987 | -127 | 3,814 | 1,742 |
Investing Cash Flow | -19,942 | -10,912 | -13,043 | -6,693 | -7,071 | -3,778 |
Total Debt Issued | 9,951 | - | - | - | - | - |
Total Debt Repaid | 1 | - | - | - | - | - |
Net Debt Issued (Repaid) | 9,952 | - | - | - | - | - |
Common Dividends Paid | -2,050 | -2,048 | -5,052 | -3,968 | -1,923 | -962 |
Other Financing Activities | -1,759 | -208 | -181 | -151 | -147 | -141 |
Financing Cash Flow | 6,143 | -2,256 | -5,233 | -4,119 | -2,070 | -1,103 |
Foreign Exchange Rate Adjustments | 587 | 1,190 | 678 | 813 | 1,008 | -215 |
Miscellaneous Cash Flow Adjustments | 50 | - | 1 | -1 | - | -2 |
Net Cash Flow | -8,936 | -6,134 | -15,886 | 26,897 | -1,148 | 8,845 |
Free Cash Flow | -8,384 | -4,027 | -11,067 | 31,150 | -5,418 | 5,256 |
Free Cash Flow Growth | - | - | - | - | - | 123.09% |
Free Cash Flow Margin | -18.99% | -8.94% | -25.44% | 39.86% | -8.00% | 11.40% |
Free Cash Flow Per Share | -69.63 | -33.44 | -91.91 | 258.69 | -44.99 | 43.65 |
Cash Interest Paid | 19 | 20 | 22 | 24 | 23 | 24 |
Cash Income Tax Paid | 654 | -86 | 2,359 | 9,902 | 5,922 | 1,854 |
Levered Free Cash Flow | -6,767 | -4,825 | -14,752 | 27,578 | -7,401 | 5,743 |
Unlevered Free Cash Flow | -6,501 | -4,813 | -14,737 | 27,593 | -7,386 | 5,758 |
Change in Working Capital | 544 | -1,134 | -3,902 | 20,086 | -19,792 | -1,817 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.